TARPLIN, DOWNS & YOUNG, LLC for AMGEN INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 18, 2014 | $60,000 | Replaced |
| 1st Quarter - Amendment | Jan 3, 2017 | $60,000 | Replaced |
| 1st Quarter - Amendment | Jan 5, 2017 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
**see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 3204 The Drug Quality and Security Act, implementation ***, no specific bill, Prescription Drug User Fee Act (PDUFA) and associated policies, 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
**see addendum pageMedicare Coverage and Reimbursement Issues ***, no specific bill number, reimbursement issues, Medicare Part B reimbursement and coverage of dialysis products, discount cards
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.